95 related articles for article (PubMed ID: 3301709)
1. Does ephedrine promote weight loss in low-energy-adapted obese women?
Pasquali R; Cesari MP; Melchionda N; Stefanini C; Raitano A; Labo G
Int J Obes; 1987; 11(2):163-8. PubMed ID: 3301709
[TBL] [Abstract][Full Text] [Related]
2. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
Astrup A; Breum L; Toubro S; Hein P; Quaade F
Int J Obes Relat Metab Disord; 1992 Apr; 16(4):269-77. PubMed ID: 1318281
[TBL] [Abstract][Full Text] [Related]
3. A controlled trial using ephedrine in the treatment of obesity.
Pasquali R; Baraldi G; Cesari MP; Melchionda N; Zamboni M; Stefanini C; Raitano A
Int J Obes; 1985; 9(2):93-8. PubMed ID: 3897082
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic administration of ephedrine during very-low-calorie diets on energy expenditure, protein metabolism and hormone levels in obese subjects.
Pasquali R; Casimirri F; Melchionda N; Grossi G; Bortoluzzi L; Morselli Labate AM; Stefanini C; Raitano A
Clin Sci (Lond); 1992 Jan; 82(1):85-92. PubMed ID: 1310922
[TBL] [Abstract][Full Text] [Related]
5. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
Muls E; Kolanowski J; Scheen A; Van Gaal L;
Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
[TBL] [Abstract][Full Text] [Related]
6. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
[TBL] [Abstract][Full Text] [Related]
7. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects.
Belza A; Frandsen E; Kondrup J
Int J Obes (Lond); 2007 Jan; 31(1):121-30. PubMed ID: 16652130
[TBL] [Abstract][Full Text] [Related]
8. The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet.
Buemann B; Marckmann P; Christensen NJ; Astrup A
Int J Obes Relat Metab Disord; 1994 May; 18(5):329-32. PubMed ID: 8061726
[TBL] [Abstract][Full Text] [Related]
9. Effect of ephedrine and theophylline on weight loss, resting energy expenditure and lipoprotein lipase activity in obese over-fed rats.
Malecka-Tendera E
Int J Obes Relat Metab Disord; 1993 Jun; 17(6):343-7. PubMed ID: 8392500
[TBL] [Abstract][Full Text] [Related]
10. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
[TBL] [Abstract][Full Text] [Related]
11. Effect of physical training on thermogenic responses to cold and ephedrine in obesity.
Nielsen B; Astrup A; Samuelsen P; Wengholt H; Christensen NJ
Int J Obes Relat Metab Disord; 1993 Jul; 17(7):383-90. PubMed ID: 8395473
[TBL] [Abstract][Full Text] [Related]
12. Aspirin potentiates the effect of ephedrine on the thermogenic response to a meal in obese but not lean women.
Horton TJ; Geissler CA
Int J Obes; 1991 May; 15(5):359-66. PubMed ID: 1885260
[TBL] [Abstract][Full Text] [Related]
13. Multivitamin and dietary supplements, body weight and appetite: results from a cross-sectional and a randomised double-blind placebo-controlled study.
Major GC; Doucet E; Jacqmain M; St-Onge M; Bouchard C; Tremblay A
Br J Nutr; 2008 May; 99(5):1157-67. PubMed ID: 17977472
[TBL] [Abstract][Full Text] [Related]
14. What do pharmacological approaches to obesity management offer? Linking pharmacological mechanisms of obesity management agents to clinical practice.
Astrup A; Lundsgaard C
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():29-34. PubMed ID: 9792479
[TBL] [Abstract][Full Text] [Related]
15. Femoxetine in the treatment of obese patients in general practice. A randomized group comparative study with placebo.
Bitsch M; Skrumsager BK
Int J Obes; 1987; 11(2):183-90. PubMed ID: 3301710
[TBL] [Abstract][Full Text] [Related]
16. The acute and chronic effects of ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans.
Toubro S; Astrup A; Breum L; Quaade F
Int J Obes Relat Metab Disord; 1993 Dec; 17 Suppl 3():S73-7; discussion S82. PubMed ID: 8124407
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans.
Fogteloo AJ; Pijl H; Frölich M; McCamish M; Meinders AE
Diabetes Nutr Metab; 2003 Apr; 16(2):109-14. PubMed ID: 12846450
[TBL] [Abstract][Full Text] [Related]
18. A dietary fibre supplement and weight maintenance after weight reduction: a randomized, double-blind, placebo-controlled long-term trial.
Ryttig KR; Tellnes G; Haegh L; Bøe E; Fagerthun H
Int J Obes; 1989; 13(2):165-71. PubMed ID: 2545640
[TBL] [Abstract][Full Text] [Related]
19. Diet, exercise, weight loss, and energy expenditure in moderately overweight women.
Belko AZ; Van Loan M; Barbieri TF; Mayclin P
Int J Obes; 1987; 11(2):93-104. PubMed ID: 3301712
[TBL] [Abstract][Full Text] [Related]
20. Changes in energy expenditure resulting from altered body weight.
Leibel RL; Rosenbaum M; Hirsch J
N Engl J Med; 1995 Mar; 332(10):621-8. PubMed ID: 7632212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
